🇺🇸 FDA

Intelligence Platform

Patents

Browse 77 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9050343

Combination of pimavanserin and risperidone for the treatment of psychosis

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921393

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822548

Compounds with activity at estrogen receptors

ACADIA Pharmaceuticals Inc. · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680115

Tetrahydroquinoline analogues as muscarinic agonists

ACADIA Pharmaceuticals Inc. · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618130

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8470872

Compounds with activity at estrogen receptors

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8377959

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8236960

Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) pheny

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227487

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101651

Compounds with activity at estrogen receptors

ACADIA Pharmaceuticals Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008323

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994193

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7923564

Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) pheny

ACADIA Pharmaceuticals Inc. · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7875632

Selective serotonin receptor inverse agonists as therapeutics for disease

ACADIA Pharmaceuticals Inc. · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7868176

Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmeth

ACADIA Pharmaceuticals Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863296

Selective serotonin receptor inverse agonists as therapeutics for disease

ACADIA Pharmaceuticals Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825265

Compounds with activity at estrogen receptors

ACADIA Pharmaceuticals Inc. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820695

Selective serotonin receptor inverse agonists as therapeutics for disease

ACADIA Pharmaceuticals Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790899

Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenyl

ACADIA Pharmaceuticals Inc. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7732615

N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbam

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7732462

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727999

Spiroazacyclic compounds as monoamine receptor modulators

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7713995

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659285

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted